COMMUNIQUÉS West-GlobeNewswire

SPINEWAY:Liquidity contract half-yearly report

12/07/2017 - 20:51

Press release Ecully, 12 July 2017 LIQUIDITY CONTRACT HALF-YEARLY REPORT Regarding liquidity contract granted by SPINEWAY to PORTZAMPARC, the liquidity account held the following assets on 30th June 2017: 20 570 shares [...]

AB Science annonce l'obtention d'un nouveau brevet européen protégeant jusqu'en 2033 l'utilisation du masitinib chez les patients atteints du cancer du pancréas

12/07/2017 - 17:56

Paris, 12 juillet 2017, 17h45 AB Science annonce l'obtention d'un nouveau brevet européen protégeant jusqu'en 2033 l'utilisation du masitinib chez les patients atteints du cancer du pancréas et présentant une douleur [...]

AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients

12/07/2017 - 17:56

Paris, 12 July 2017, 5.45pm AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients with pain until 2033 Recruitment target before possible resampling of [...]

AB Science annonce l'obtention d'un nouveau brevet européen protégeant jusqu'en 2033 l'utilisation du masitinib chez les patients atteints du cancer du pancréas

12/07/2017 - 17:46

Paris, 12 juillet 2017, 17h45 AB Science annonce l'obtention d'un nouveau brevet européen protégeant jusqu'en 2033 l'utilisation du masitinib chez les patients atteints du cancer du pancréas et présentant une douleur [...]

AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients

12/07/2017 - 17:46

Paris, 12 July 2017, 5.45pm AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients with pain until 2033 Recruitment target before possible resampling of [...]

FIT Biotech Oy: FIT Biotech Receives EUR 644,868 Payment from European HIV Vaccine Alliance (EHVA)

12/07/2017 - 15:00

FIT Biotech Oy Company release 12 July, 2017 at 4:00 PM EET FIT Biotech Receives EUR 644,868 Payment from European HIV Vaccine Alliance (EHVA) FIT Biotech Oy ("Company") has received today a EUR 644,868 payment from its [...]

RedHill Biopharma Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn's Disease

12/07/2017 - 14:00

The second independent Data and Safety Monitoring Board (DSMB) meeting of the RHB-104 Phase III study for Crohn's disease (MAP US study) is planned to be held in late July 2017 and will assess the safety and efficacy of [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

12/07/2017 - 09:00

FIT Biotech Oy Company release July 12, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Biocartis Group NV: Biocartis' Idylla(TM) Instrument and Idylla(TM) Console exempt from US FDA 510(k) notification requirements

12/07/2017 - 07:00

PRESS RELEASE: 12 July 2017, 07:00 CEST Biocartis' Idylla(TM) Instrument and Idylla(TM) Console exempt from US FDA 510(k) notification requirements Mechelen (Belgium), 12 July 2017 - Biocartis Group NV ('Biocartis' or [...]

VIFOR PHARMA ANNOUNCES THREE OUTCOMES TRIALS IN HEART FAILURE AND IRON DEFICIENCY

12/07/2017 - 06:59

PRESS RELEASE This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Merus Announces First Quarter 2017 Financial Results and Mid-Year Operating Results

11/07/2017 - 22:05

Balance sheet strengthened with $120 million upfront payment and an $80 million share purchase from Incyte Corporation for global strategic research collaboration to discover and develop bispecific antibodies Based on [...]

IBA SA : NOTIFICATION DE TRANSPARENCE

11/07/2017 - 18:00

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 10 juillet 2017, 17h40 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

IBA SA : TRANSPARENCY NOTIFICATION

11/07/2017 - 18:00

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, July 10, 2017, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation

11/07/2017 - 16:00

DUBLIN - July 11, 2017 - Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the safety and effectiveness of performing pulmonary vein isolation (PVI [...]

MPI - Last day of trading in paid subscription shares

11/07/2017 - 15:21

Hoersholm, Denmark, July 11 th 2017 - Medical Prognosis Institute A/S ("MPI") completed a rights issue of shares in June 2017 where the public also could subscribe for shares. Through the rights issue 694,715 shares [...]

Novo Nordisk A/S - Share repurchase programme

11/07/2017 - 14:37

Bagsværd, Denmark, 11 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Nutrition International : Nutrition International and UNFPA partner to improve women and adolescent girls' health

11/07/2017 - 14:00

LONDON, UK--(Marketwired - July 11, 2017) - Nutrition International and UNFPA, the United Nations Populations Fund , announced today at the Family Planning Summit 2020 in London, a partnership to provide services [...]

Bavarian Nordic A/S - Articles of Association

11/07/2017 - 13:54

Updated Articles of Association for Bavarian Nordic A/S BavarianNordicArticlesofAssociation This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The [...]

uniQure Presents New Clinical Data in Hemophilia B Patients Demonstrating Therapeutic Efficacy of AAV5 Gene Therapy in the Presence of Pre-Existing Neutralizing Antibodies

11/07/2017 - 12:30

-- Findings Further Support Expanding the Eligibility of AAV5 Gene Therapies to Nearly All Patients with Hemophilia B -- LEXINGTON, Mass. and AMSTERDAM, the Netherlands, July 11, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. ( [...]